389 related articles for article (PubMed ID: 24755204)
1. AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.
Szczesny B; Módis K; Yanagi K; Coletta C; Le Trionnaire S; Perry A; Wood ME; Whiteman M; Szabo C
Nitric Oxide; 2014 Sep; 41():120-30. PubMed ID: 24755204
[TBL] [Abstract][Full Text] [Related]
2. AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo.
Ahmad A; Olah G; Szczesny B; Wood ME; Whiteman M; Szabo C
Shock; 2016 Jan; 45(1):88-97. PubMed ID: 26513708
[TBL] [Abstract][Full Text] [Related]
3. The novel mitochondria-targeted hydrogen sulfide (H
Gerő D; Torregrossa R; Perry A; Waters A; Le-Trionnaire S; Whatmore JL; Wood M; Whiteman M
Pharmacol Res; 2016 Nov; 113(Pt A):186-198. PubMed ID: 27565382
[TBL] [Abstract][Full Text] [Related]
4. Both the H
Ahmad A; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):348-355. PubMed ID: 27639598
[TBL] [Abstract][Full Text] [Related]
5. AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons.
Zhao FL; Fang F; Qiao PF; Yan N; Gao D; Yan Y
Oxid Med Cell Longev; 2016; 2016():8360738. PubMed ID: 27057285
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice.
Ikeda K; Marutani E; Hirai S; Wood ME; Whiteman M; Ichinose F
Nitric Oxide; 2015 Sep; 49():90-6. PubMed ID: 25960429
[TBL] [Abstract][Full Text] [Related]
7. AP39 ameliorates high fat diet-induced liver injury in young rats via alleviation of oxidative stress and mitochondrial impairment.
Yu Y; Ye SM; Liu DY; Yang LQ
Exp Anim; 2021 Nov; 70(4):553-562. PubMed ID: 34305077
[TBL] [Abstract][Full Text] [Related]
8. The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H
Pomierny B; Krzyżanowska W; Jurczyk J; Skórkowska A; Strach B; Szafarz M; Przejczowska-Pomierny K; Torregrossa R; Whiteman M; Marcinkowska M; Pera J; Budziszewska B
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360581
[TBL] [Abstract][Full Text] [Related]
9. AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia Pathogenesis.
Covarrubias AE; Lecarpentier E; Lo A; Salahuddin S; Gray KJ; Karumanchi SA; Zsengellér ZK
Am J Pathol; 2019 Jan; 189(1):104-114. PubMed ID: 30315766
[TBL] [Abstract][Full Text] [Related]
10. The mitochondria-targeted hydrogen sulfide donor AP39 improves health and mitochondrial function in a C. elegans primary mitochondrial disease model.
Fox BC; Slade L; Torregrossa R; Pacitti D; Szabo C; Etheridge T; Whiteman M
J Inherit Metab Dis; 2021 Mar; 44(2):367-375. PubMed ID: 33325042
[TBL] [Abstract][Full Text] [Related]
11. SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells.
Xie L; Feng H; Li S; Meng G; Liu S; Tang X; Ma Y; Han Y; Xiao Y; Gu Y; Shao Y; Park CM; Xian M; Huang Y; Ferro A; Wang R; Moore PK; Wang H; Ji Y
Antioxid Redox Signal; 2016 Feb; 24(6):329-43. PubMed ID: 26422756
[TBL] [Abstract][Full Text] [Related]
12. H
Juriasingani S; Akbari M; Chan JY; Whiteman M; Sener A
Nitric Oxide; 2018 Dec; 81():57-66. PubMed ID: 30393129
[TBL] [Abstract][Full Text] [Related]
13. AP39, a novel mitochondria-targeted hydrogen sulfide donor ameliorates doxorubicin-induced cardiotoxicity by regulating the AMPK/UCP2 pathway.
Zhang B; Li Y; Liu N; Liu B
PLoS One; 2024; 19(4):e0300261. PubMed ID: 38568919
[TBL] [Abstract][Full Text] [Related]
14. AP39, a mitochondria-targeting hydrogen sulfide (H
Karwi QG; Bornbaum J; Boengler K; Torregrossa R; Whiteman M; Wood ME; Schulz R; Baxter GF
Br J Pharmacol; 2017 Feb; 174(4):287-301. PubMed ID: 27930802
[TBL] [Abstract][Full Text] [Related]
15. Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells.
Fink BD; Herlein JA; Yorek MA; Fenner AM; Kerns RJ; Sivitz WI
J Pharmacol Exp Ther; 2012 Sep; 342(3):709-19. PubMed ID: 22661629
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors
Latorre E; Torregrossa R; Wood ME; Whiteman M; Harries LW
Aging (Albany NY); 2018 Jul; 10(7):1666-1681. PubMed ID: 30026406
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 6 is essential for sodium sulfide-mediated cytoprotective effect in ischemia/reperfusion-stimulated brain endothelial cells.
Hu Y; Li R; Yang H; Luo H; Chen Z
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):601-9. PubMed ID: 25543188
[TBL] [Abstract][Full Text] [Related]
18. 3-Mercaptopyruvate sulfurtransferase/hydrogen sulfide protects cerebral endothelial cells against oxygen-glucose deprivation/reoxygenation-induced injury via mitoprotection and inhibition of the RhoA/ROCK pathway.
Zhang F; Chen S; Wen JY; Chen ZW
Am J Physiol Cell Physiol; 2020 Oct; 319(4):C720-C733. PubMed ID: 32813542
[TBL] [Abstract][Full Text] [Related]
19. A novel controllable hydrogen sulfide-releasing molecule protects human skin keratinocytes against methylglyoxal-induced injury and dysfunction.
Yang CT; Zhao Y; Xian M; Li JH; Dong Q; Bai HB; Xu JD; Zhang MF
Cell Physiol Biochem; 2014; 34(4):1304-17. PubMed ID: 25277151
[TBL] [Abstract][Full Text] [Related]
20. Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity.
Castilho Á; Aveleira CA; Leal EC; Simões NF; Fernandes CR; Meirinhos RI; Baptista FI; Ambrósio AF
PLoS One; 2012; 7(8):e42428. PubMed ID: 22879979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
